secwatch.observer — SEC 8-K summary
======================================

Issuer:     Silo Pharma, Inc. (SILO)
CIK:        0001514183
Form:       8-K
Filed at:   2022-01-04T23:59:59+00:00
Accession:  0001213900-22-000462
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Silo Pharma sets director compensation: $25k retainer + options, $0.1460 strike, one-year vest
--------------------------------------------------------------------------------

- Non-employee directors receive $25,000 cash retainer plus 177,233 option shares at $0.1460, one-year cliff vest.
- Audit Committee Chair receives additional $12,500 cash fee.
- Compensation Committee Chair receives additional $7,500 cash fee.
- Option term is 5 years from grant date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1514183/000121390022000462/0001213900-22-000462-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1514183/000121390022000462/ea153452-8k_silopharma.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-000462

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer